Mucinex D

   
Google
 
Web NewDrugInformation.com

Mucinex D


Drug - Mucinex D
The trade name of the product as shown on the labeling.

Dosage - TABLET, EXTENDED RELEASE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Guaifenesin; Pseudoephedrine Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 1.2GM;120MG
The potency of the active ingredient(s), Guaifenesin; Pseudoephedrine Hydrochloride. May repeat for multiple part products.

Applicant - ADAMS LABS INC
The firm name holding legal responsibility for Mucinex D. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 021585
The FDA assigned number to Mucinex D. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Mucinex D. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jun 22, 2004
The date Mucinex D was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Mucinex D. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - OTC
The group or category of approved drugs Mucinex D is in. Format is RX, OTC, DISCN.

Applicant Full Name - Adams Laboratories Inc Dba Adams Respiratory Therapeutics
The full name of the firm holding legal responsibility for the new application of Mucinex D.

Mucinex D